Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial
Table 2
Comparison of hemograms between two groups.
Time
WBC (109/L)
RBC
Hb (g/L)
PLT (109/L)
Group A
Baseline
3.31 (0.25)
2.49 (0.13)
87.90 (4.16)
31.61 (4.83)
After treatment
4.32 (0.21)
3.01 (0.14)
109.30 (4.63)
49.13 (7.05)
t value
3.20
2.73
3.48
2.09
value
0.002
0.008
0.001
0.041
Group B
Baseline
3.40 (0.19)
2.31 (0.09)
81.20 (3.89)
34.33 (4.43)
After treatment
3.89 (0.28)
2.81 (0.10)
96.76 (3.58)
44.13 (5.26)
t value
1.446
3.71
2.95
1.423
value
0.153
<0.000
0.004
0.159
WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; PLT, platelet. .
